API0232512

Bexagliflozin

Bexagliflozin is an SGLT2 inhibitor, antidiabetic drug.

Product Size

Quantity

Pharm Gradet

Standard

Registration

Inquiry

API Description

API Details

Document

Related Patent Status

Molecular Weight (g/mol)

464.9
Molecular Formula

C24H29ClO7
InChI

InChI=1S/C24H29ClO7/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2/t20-,21-,22+,23-,24+/m1/s1
InChIKey

BTCRKOKVYTVOLU-SJSRKZJXSA-N
SMILES

C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
IUPAC Name

(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
Exact Mass (Da)

464.160181
Monoisotopic Mass (Da)

464.160181

OUR PRODUCTS